Cigna Corporation Financial Statements (CI) |
||||||||||
Cigna Corporationsmart-lab.ru | % | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 31.12.2023 | 29.02.2024 | 02.05.2024 | 01.08.2024 | 31.10.2024 | 31.10.2024 | ||||
Currency | USD | USD | USD | USD | USD | USD | ||||
Financial report URL | ||||||||||
Revenue, bln rub | ? | 51 114 | 51 080 | 55 419 | 60 475 | 63 694 | 230 668 | |||
Operating Income, bln rub | 1 029 | 1 029 | 2 256 | 2 412 | 1 732 | 7 429 | ||||
EBITDA, bln rub | ? | 1 029 | 1 313 | 1 142 | 3 102 | 2 218 | 7 775 | |||
Net profit, bln rub | ? | 1 029 | 1 029 | -277.0 | 1 548 | 86.0 | 2 386 | |||
OCF, bln rub | ? | 0.000 | 1 467 | 4 840 | 265.0 | 46.0 | 6 618 | |||
CAPEX, bln rub | ? | 0.000 | 365.0 | 300.0 | 370.0 | 399.0 | 1 434 | |||
FCF, bln rub | ? | 0.000 | 1 102 | 4 540 | -105.0 | -353.0 | 5 184 | |||
Dividend payout, bln rub | 0.000 | 358.0 | 401.0 | 392.0 | 390.0 | 1 541 | ||||
Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
Dividend payout ratio, % | 0.00% | 34.8% | 0.00% | 25.3% | 453.5% | 64.6% | ||||
OPEX, bln rub | 50 085 | 39 497 | 45 522 | 48 533 | 3 590 | 137 142 | ||||
Cost of production, bln rub | 0.000 | 9 280 | 9 440 | 9 515 | 9 527 | 37 762 | ||||
R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
Interest expenses, bln rub | 0.000 | 360.0 | 322.0 | 375.0 | 376.0 | 1 433 | ||||
Assets, bln rub | 0.000 | 147 926 | 148 447 | 150 851 | 157 639 | 157 639 | ||||
Net Assets, bln rub | ? | 46 223 | 46 223 | 41 181 | 41 332 | 42 095 | 42 095 | |||
Debt, bln rub | 0.000 | 31 480 | 32 768 | 31 892 | 32 802 | 32 802 | ||||
Cash, bln rub | 0.000 | 8 747 | 9 547 | 7 856 | 5 888 | 5 888 | ||||
Net debt, bln rub | 0.00 | 22 733 | 23 221 | 24 036 | 26 914 | 26 914 | ||||
Ordinary share price, rub | 299.5 | 299.5 | 363.2 | 330.6 | 346.4 | 318.9 | ||||
Number of ordinary shares, mln | 294.6 | 292.5 | 286.5 | 281.1 | 278.5 | 278.5 | ||||
Market cap, bln rub | 88 207 | 87 590 | 104 041 | 92 934 | 96 469 | 88 800 | ||||
EV, bln rub | ? | 88 207 | 110 323 | 127 262 | 116 970 | 123 383 | 115 714 | |||
Book value, bln rub | 46 223 | -28 899 | -33 568 | -33 102 | -32 070 | -32 070 | ||||
EPS, rub | ? | 3.49 | 3.52 | -0.97 | 5.51 | 0.31 | 8.57 | |||
FCF/share, rub | 0.00 | 3.77 | 15.8 | -0.37 | -1.27 | 18.6 | ||||
BV/share, rub | 156.9 | -98.8 | -117.2 | -117.7 | -115.2 | -115.2 | ||||
EBITDA margin, % | ? | 2.01% | 2.57% | 2.06% | 5.13% | 3.48% | 3.37% | |||
Net margin, % | ? | 2.01% | 2.01% | -0.50% | 2.56% | 0.14% | 1.03% | |||
FCF yield, % | ? | 10.4% | 11.7% | 9.77% | 8.57% | 5.37% | 5.84% | |||
ROE, % | ? | 8.21% | 8.21% | 5.47% | 5.66% | 5.67% | 5.67% | |||
ROA, % | ? | 2.57% | 1.52% | 1.55% | 1.51% | 1.51% | ||||
P/E | ? | 23.2 | 23.1 | 46.2 | 39.7 | 40.4 | 37.2 | |||
P/FCF | 9.65 | 8.55 | 10.2 | 11.7 | 18.6 | 17.1 | ||||
P/S | ? | 0.45 | 0.45 | 0.51 | 0.43 | 0.42 | 0.38 | |||
P/BV | ? | 1.91 | -3.03 | -3.10 | -2.81 | -3.01 | -2.77 | |||
EV/EBITDA | ? | 11.8 | 12.9 | 16.6 | 13.7 | 15.9 | 14.9 | |||
Debt/EBITDA | 0.00 | 2.67 | 3.04 | 2.82 | 3.46 | 3.46 | ||||
R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
CAPEX/Revenue, % | 0.00% | 0.71% | 0.54% | 0.61% | 0.63% | 0.62% | ||||
Cigna Corporation shareholders |